Can probiotics (Probiotic Supplements) be taken with antibiotics (Antibacterial Medications)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Probiotics with Antibiotics: Recommendations for Safe and Effective Use

Probiotics can and should be taken with antibiotics to reduce the risk of antibiotic-associated diarrhea (AAD), but they should be administered at least 2 hours apart from antibiotics and are contraindicated in immunocompromised patients due to risk of bacteremia. 1

Benefits of Combining Probiotics with Antibiotics

  • Probiotics reduce the incidence of antibiotic-associated diarrhea (AAD) by approximately 38% 2
  • They help restore gut microbiota balance disrupted by antibiotic therapy 1
  • Specific strains have shown effectiveness in preventing Clostridioides difficile infection 3
  • Improved adherence to antibiotic regimens due to reduced gastrointestinal side effects 4

Optimal Timing and Administration

  1. Start probiotics early: Begin within 24-48 hours of starting antibiotic therapy 1
  2. Separate administration: Take probiotics at least 2 hours apart from antibiotics 1
  3. Continue after antibiotics: Maintain probiotic therapy for 1-2 weeks after completing antibiotics 1
  4. Dosage matters: Higher doses (≥5 billion CFU/day) show greater efficacy 1, 5

Most Effective Probiotic Strains

  • Saccharomyces boulardii: 10-11 billion CFU/day - particularly effective for AAD prevention 1, 3
  • Lactobacillus rhamnosus: ≥11 billion CFU/day - proven safe and effective 1
  • Multi-strain combinations: Generally more effective than single strains 1
    • Combination of Lactobacillus acidophilus CL1285, L. casei LBC80R, and L. rhamnosus CLR2 has shown effectiveness in reducing C. difficile infection rates in hospital settings 3

Important Safety Considerations

Absolute contraindications:

  • Immunocompromised patients 3, 1
  • Critically ill patients 6
  • Patients with central venous catheters 6
  • Patients at risk of bacteremia or fungemia 3

Common side effects:

  • Mild bloating and flatulence 6
  • Abdominal discomfort 1
  • Rarely, constipation 1

Special Populations and Considerations

  • Hospital inpatients: Probiotics may be considered during high-risk periods (such as outbreaks) for preventing C. difficile infection 3
  • Recurrent C. difficile infection: Probiotics (particularly S. boulardii) may be an effective adjunct to standard antibiotic treatment (vancomycin) 3
  • Pediatric patients: Evidence supports probiotic use in children receiving antibiotics, with reduction in AAD from 19% to 8% 1

Practical Implementation Algorithm

  1. Assess patient risk factors:

    • If immunocompromised, critically ill, or with central venous catheter → DO NOT use probiotics
    • If history of recurrent C. difficile → Consider S. boulardii with high-dose vancomycin
  2. Select appropriate probiotic:

    • For general AAD prevention → S. boulardii (≥10 billion CFU/day) or multi-strain product
    • For C. difficile prevention → Multi-strain product containing L. acidophilus CL1285, L. casei LBC80R, L. rhamnosus CLR2
  3. Establish administration schedule:

    • Morning antibiotic dose → Probiotic at midday (≥2 hours later)
    • Evening antibiotic dose → Probiotic before bed (≥2 hours later)
  4. Monitor for effectiveness and adverse effects:

    • Reduced incidence of diarrhea indicates effectiveness
    • Discontinue if significant bloating or discomfort occurs

By following these evidence-based recommendations, probiotics can be safely and effectively used alongside antibiotics to reduce the risk of antibiotic-associated diarrhea and potentially prevent C. difficile infection in appropriate patient populations.

References

Guideline

Managing Loose Bowel Movements after Antibiotics

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Probiotics.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.